139 related articles for article (PubMed ID: 29596526)
21. Methods, safety, and early clinical outcomes of dose escalation using simultaneous integrated and sequential boosts in patients with locally advanced gynecologic malignancies.
Boyle J; Craciunescu O; Steffey B; Cai J; Chino J
Gynecol Oncol; 2014 Nov; 135(2):239-43. PubMed ID: 25192879
[TBL] [Abstract][Full Text] [Related]
22. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
Shao N; Cai Q
Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
[TBL] [Abstract][Full Text] [Related]
23. Preoperative intensity modulated radiation therapy and chemotherapy for locally advanced vulvar carcinoma: analysis of pattern of relapse.
Beriwal S; Shukla G; Shinde A; Heron DE; Kelley JL; Edwards RP; Sukumvanich P; Richards S; Olawaiye AB; Krivak TC
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1269-74. PubMed ID: 23273997
[TBL] [Abstract][Full Text] [Related]
24. Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?
Vidal F; Guerby P; Luyckx M; Haddad P; Stoeckle E; Morice P; Leblanc E; Lecuru F; Daraï E; Classe JM; Pomel C; Filleron T; Ferron G; Querleu D; Rafii A
PLoS One; 2016; 11(1):e0147787. PubMed ID: 26820579
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer.
Woelber L; Mahner S; Voelker K; Eulenburg CZ; Gieseking F; Choschzick M; Jaenicke F; Schwarz J
Anticancer Res; 2009 Feb; 29(2):545-52. PubMed ID: 19331201
[TBL] [Abstract][Full Text] [Related]
26. ABO and Rh blood groups in relation to ovarian, endometrial and cervical cancer risk among the population of South-East Siberia.
Yuzhalin AE; Kutikhin AG
Asian Pac J Cancer Prev; 2012; 13(10):5091-6. PubMed ID: 23244116
[TBL] [Abstract][Full Text] [Related]
27. The clinical outcome of epithelial ovarian cancer patients with apparently isolated lymph node recurrence: a multicenter retrospective Italian study.
Gadducci A; Cosio S; Zola P; Sostegni B; Ferrero AM; Teti G; Cristofani R; Sartori E
Gynecol Oncol; 2010 Mar; 116(3):358-63. PubMed ID: 19954826
[TBL] [Abstract][Full Text] [Related]
28. Survival benefit of hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer: a multi-institutional case control study.
Le Brun JF; Campion L; Berton-Rigaud D; Lorimier G; Marchal F; Ferron G; Oger AS; Dravet F; Jaffre I; Classe JM
Ann Surg Oncol; 2014 Oct; 21(11):3621-7. PubMed ID: 24819120
[TBL] [Abstract][Full Text] [Related]
29. [Analysis of risk factors for epithelial ovarian cancer recurrence].
Liu S; Liu JH; Huang H; Peng XP; Wang YM
Ai Zheng; 2003 Nov; 22(11):1197-200. PubMed ID: 14613652
[TBL] [Abstract][Full Text] [Related]
30. Vulvar cancer: prognostic factors.
Nicoletto MO; Parenti A; Del Bianco P; Lombardi G; Pedrini L; Pizzi S; Carli P; Della Palma M; Pastorelli D; Corti L; Becagli L
Anticancer Res; 2010 Jun; 30(6):2311-7. PubMed ID: 20651385
[TBL] [Abstract][Full Text] [Related]
31. Venous thromboembolism during primary treatment of ovarian clear cell carcinoma is associated with decreased survival.
Diaz ES; Walts AE; Karlan BY; Walsh CS
Gynecol Oncol; 2013 Dec; 131(3):541-5. PubMed ID: 24041880
[TBL] [Abstract][Full Text] [Related]
32. HE4 expression in plasma correlates with surgical outcome and overall survival in patients with first ovarian cancer relapse.
Braicu EI; Chekerov R; Richter R; Pop C; Nassir M; Loefgren H; Stamatian F; Muallem MZ; Hall C; Fotopoulou C; Sehouli J; Pietzner K
Ann Surg Oncol; 2014 Mar; 21(3):955-62. PubMed ID: 24217786
[TBL] [Abstract][Full Text] [Related]
33. Ovarian cancer and ABO blood groups.
Henderson J; Seagroatt V; Goldacre M
J Epidemiol Community Health; 1993 Aug; 47(4):287-9. PubMed ID: 8228763
[TBL] [Abstract][Full Text] [Related]
34. "The impact of debulking surgery in patients with node-positive epithelial ovarian cancer: Analysis of prognostic factors related to overall survival and progression-free survival after an extended long-term follow-up period".
Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Cuesta-Guardiola T; Peregrin I; Mendizabal E; Lizarraga S; Ortiz-Quintana L
Surg Oncol; 2016 Mar; 25(1):49-59. PubMed ID: 26979641
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors for recurrence and survival in primary vulvar squamous cell cancer.
Ayhan A; Velipasaoglu M; Salman MC; Guven S; Gultekin M; Bayraktar O
Acta Obstet Gynecol Scand; 2008; 87(11):1143-9. PubMed ID: 18949585
[TBL] [Abstract][Full Text] [Related]
36. Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter study.
Woelber L; Griebel LF; Eulenburg C; Sehouli J; Jueckstock J; Hilpert F; de Gregorio N; Hasenburg A; Ignatov A; Hillemanns P; Fuerst S; Strauss HG; Baumann KH; Thiel FC; Mustea A; Meier W; Harter P; Wimberger P; Hanker LC; Schmalfeldt B; Canzler U; Fehm T; Luyten A; Hellriegel M; Kosse J; Heiss C; Hantschmann P; Mallmann P; Tanner B; Pfisterer J; Richter B; Neuser P; Mahner S
Eur J Cancer; 2016 Dec; 69():180-188. PubMed ID: 27837710
[TBL] [Abstract][Full Text] [Related]
37. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
[TBL] [Abstract][Full Text] [Related]
38. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
39. Characteristic features of recurrences of squamous cell carcinoma of the vulva.
Sznurkowski JJ; Emerich J
Ginekol Pol; 2010 Jan; 81(1):12-9. PubMed ID: 20232693
[TBL] [Abstract][Full Text] [Related]
40. Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery.
Forget P; Machiels JP; Coulie PG; Berliere M; Poncelet AJ; Tombal B; Stainier A; Legrand C; Canon JL; Kremer Y; De Kock M
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S650-60. PubMed ID: 23884751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
